https://orcid.org/0000-0002-4953-5239
References
- Wyburn-Mason R. Malignant change arising in tissues affected by herpes. Br Med J. 1955;2(4948):1106–1109. doi:10.1136/bmj.2.4948.1106
- Wolf R, Brenner S, Ruocco V, Filioli FG. Isotopic response. Int J Dermatol. 1995;34(5):341–348. doi:10.1111/j.1365-4362.1995.tb03616.x
- Mahajan R, Saikia U, Mahajan R. Wolf’s isotopic response: report of a case and review of literature. Indian J Dermatol. 2014;59(3):275–282. doi:10.4103/0019-5154.131401
- Lee J-H, Lee S-K, Kim J-H, Kim H-Y, Myoung-Shin K, Lee U-H. A case of eosinophilic pustular folliculitis associated with herpes zoster. Am J Dermatopathol. 2021;43(4):298–299. doi:10.1097/DAD.0000000000001818
- Nomura T, Katoh M, Yamamoto Y, Miyachi Y, Kabashima K. Eosinophilic pustular folliculitis: a proposal of diagnostic and therapeutic algorithms. J Dermatol. 2016;43(11):1301–1306. doi:10.1111/1346-8138.13359
- Amerio P, Frezzolini A, Feliciani C, et al. Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications. Curr Drug Targets Inflamm Allergy. 2003;2(1):81–94. doi:10.2174/1568010033344480
- Nakahigashi K, Doi H, Otsuka A, et al. PGD2 induces eotaxin-3 via PPARγ from sebocytes: a possible pathogenesis of eosinophilic pustular folliculitis. J Allergy Clin Immunol. 2012;29(2):536–543. doi:10.1016/j.jaci.2011.11.034
- Monastirli A, Antoniades G, Kapranos N, Pasmatzi E, Badavanis G, Tsambaos D. Classic form of eosinophilic pustular folliculitis in an immunocompetent girl: rapid and complete resolution after low-dose oral indomethacin treatment. Dermatol Online J. 2017;23:11. PMID: 29447640. doi:10.5070/D32311037269
- Simon D, Simon H-U. Therapeutic strategies for eosinophilic dermatoses. Curr Opin Pharmacol. 2019;46:29–33. doi:10.1016/j.coph.2019.01.002
- Yang R, Wang L-Q, Yuan B-C, Liu Y. The pharmacological activities of licorice. Planta Med. 2015;81(18):1654–1669. doi:10.1055/s-0035-1557893